Qrono

0 followers


Qrono is rewriting cancer’s story with a new class of patentable therapy that changes tumor-immune cell communication.

Industries

Headquarters

Stage

Employees

Links

Org chart

Sam Rothstein
CEO & Co-Founder

Sam Rothstein

Collapse
Christina Cargill, PhD
Head Of Research
Steven Little
Co-Founder